The National Institute for Health and Care Excellence (NICE) has issued a new quality standard which focuses on management of Parkinson’s disease in adult patients with respect to high-quality care in priority areas for improvement. Management of parkinsonism unrelated to Parkinson’s disease is not included in the scope of the quality standard.
The key goals of the quality standard are:
- Improving health-related and carer QoL.
- Improving self-management and patient experience.
- Improving outcomes of falls.
- Improving outcomes of hospital admissions, readmissions and length of stay.
- Improving patient safety incidents in hospital.
- Improving mortality outcomes.
The quality standard covers 5 recommendations:
- Affected individuals should have a point of contact with specialist services.
- Individuals receiving dopaminergic therapy should be informed about the risk for impulse control disorders, when initiating treatment and at least once a year.
- Referral to physiotherapy, occupational therapy or speech and language therapy is recommended in case of issues with balance, motor function, activities of daily living, communication, swallowing or saliva.
- Individuals in a hospital or a care home should receive levodopa within 30 minutes of their individually prescribed administration time.
- Some individuals may require access to clozapine and patient monitoring for treating hallucinations and delusions.
Health professionals should also take into consideration several other quality standards on dementia, depression, multi-morbidity and geriatric care when providing services for Parkinson’s disease.